These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 6306106)

  • 1. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
    Santoli D; Francis MK; Matera L; Ferrero D
    J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.
    Matera L; Francis MK; Herlyn M; Trucco M; Santoli D
    Nat Immun Cell Growth Regul; 1985; 4(2):90-102. PubMed ID: 3160934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessory function and interleukin 1 production by human leukemic cell lines.
    Wakasugi H; Harel A; Dokhelar MC; Fradelizi D; Tursz T
    J Immunol; 1984 Jun; 132(6):2939-47. PubMed ID: 6373923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor.
    Imaizumi M; Uozumi J; Breitman TR
    Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
    Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
    Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
    Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
    Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells.
    Hickstein DD; Smith A; Fisher W; Beatty PG; Schwartz BR; Harlan JM; Root RK; Locksley RM
    J Immunol; 1987 Jan; 138(2):513-9. PubMed ID: 2947951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cell surface glycoproteins and antigens during differentiation of the human myeloid leukemia cell lines ML-1, ML-2, and HL-60.
    Stöckbauer P; Gahmberg CG; Andersson LC
    Cancer Res; 1985 Jun; 45(6):2821-6. PubMed ID: 3857122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines.
    Kaplinsky C; Estrov Z; Freedman MH; Cohen A
    Blood Cells; 1986; 11(3):459-68. PubMed ID: 3461855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
    Ghezzo F; Palumbo A; Pegoraro L
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1355-9. PubMed ID: 6934784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
    Santoli D; Francis MK; Matera L
    Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tumor promoters on the expression of a tumor-related multigenic set in human cells.
    Hanania N; Castagna M; Shaool D; Zeliszewski D; Harel J
    Cancer Res; 1985 Dec; 45(12 Pt 1):6058-62. PubMed ID: 3933820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned medium.
    Dayton ET; Perussia B; Trinchieri G
    J Immunol; 1983 Mar; 130(3):1120-8. PubMed ID: 6185572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
    Kelley VE; Fiers W; Strom TB
    J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation.
    Miller LJ; Schwarting R; Springer TA
    J Immunol; 1986 Nov; 137(9):2891-900. PubMed ID: 2428876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages.
    Sutherland JA; Turner AR; Mannoni P; McGann LE; Turc JM
    J Biol Response Mod; 1986 Jun; 5(3):250-62. PubMed ID: 2425057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glucocorticoid receptor concentration in macrophage differentiation of myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate.
    Hirai H; Murakami T; Urabe A; Takaku F
    Cancer Res; 1985 Jun; 45(6):2456-61. PubMed ID: 3857120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
    Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U
    Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
    Pesando JM; Graf L; Hoffman P
    J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.